Literature DB >> 28780934

SOX4: Joining the Master Regulators of Epithelial-to-Mesenchymal Transition?

Ana Rita Lourenço1, Paul J Coffer2.   

Abstract

The epithelial-to-mesenchymal transition (EMT) is an important developmental program exploited by cancer cells to gain mesenchymal features. Transcription factors globally regulating processes during EMT are often referred as 'master regulators' of EMT, and include members of the Snail and ZEB transcription factor families. The SRY-related HMG box (SOX) 4 transcription factor can promote tumorigenesis by endowing cells with migratory and invasive properties, stemness, and resistance to apoptosis, thereby regulating key aspects of the EMT program. We propose here that SOX4 should also be considered as a master regulator of EMT, and we review the molecular mechanisms underlying its function.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28780934     DOI: 10.1016/j.trecan.2017.06.002

Source DB:  PubMed          Journal:  Trends Cancer        ISSN: 2405-8025


  27 in total

Review 1.  SOX4: The unappreciated oncogene.

Authors:  Carlos S Moreno
Journal:  Semin Cancer Biol       Date:  2019-08-21       Impact factor: 15.707

2.  Molecules in the blood of older people promote cancer spread.

Authors:  Hai Wang; Xiang H-F Zhang
Journal:  Nature       Date:  2020-09       Impact factor: 49.962

Review 3.  Roles and regulation of SOX transcription factors in skeletogenesis.

Authors:  Véronique Lefebvre
Journal:  Curr Top Dev Biol       Date:  2019-02-26       Impact factor: 4.897

4.  Amazonian Guarana- and Açai-Conjugated Extracts Improve Scratched Fibroblast Healing and Eisenia fetida Surgical Tail Amputation by Modulating Oxidative Metabolism.

Authors:  Fellipe D Felin; Ednea A Maia-Ribeiro; Carollina D Felin; Nathália A C Bonotto; Bárbara O Turra; Isabel Roggia; Verônica F Azzolin; Cibele F Teixeira; Moisés H Mastella; Carolina Rodrigues de Freitas; Jaqueline Greijanim; Daniel Santos; Erico M M Flores; Fernanda Barbisan; Ivana B M Cruz; Tiango A Ribeiro
Journal:  Oxid Med Cell Longev       Date:  2022-06-26       Impact factor: 7.310

5.  Long noncoding RNA lncBRM facilitates the proliferation, migration and invasion of ovarian cancer cells via upregulation of Sox4.

Authors:  Jie Xi; Jing Feng; Saitian Zeng
Journal:  Am J Cancer Res       Date:  2017-11-01       Impact factor: 6.166

6.  Transcriptional profiling reveals gland-specific differential expression in the three major salivary glands of the adult mouse.

Authors:  Xin Gao; Maria S Oei; Catherine E Ovitt; Murat Sincan; James E Melvin
Journal:  Physiol Genomics       Date:  2018-01-26       Impact factor: 3.107

7.  Selective Translation of Cell Fate Regulators Mediates Tolerance to Broad Oncogenic Stress.

Authors:  Elise Y Cai; Megan N Kufeld; Samantha Schuster; Sonali Arora; Madeline Larkin; Alexandre A Germanos; Andrew C Hsieh; Slobodan Beronja
Journal:  Cell Stem Cell       Date:  2020-06-08       Impact factor: 24.633

8.  Apobec1 complementation factor overexpression promotes hepatic steatosis, fibrosis, and hepatocellular cancer.

Authors:  Valerie Blanc; Jesse D Riordan; Saeed Soleymanjahi; Joseph H Nadeau; ILKe Nalbantoglu; Yan Xie; Elizabeth A Molitor; Blair B Madison; Elizabeth M Brunt; Jason C Mills; Deborah C Rubin; Irene O Ng; Yeonjung Ha; Lewis R Roberts; Nicholas O Davidson
Journal:  J Clin Invest       Date:  2021-01-04       Impact factor: 14.808

9.  miR-425 suppresses EMT and the development of TNBC (triple-negative breast cancer) by targeting the TGF-β 1/SMAD 3 signaling pathway.

Authors:  Yingping Liu; Jinglong Chen
Journal:  RSC Adv       Date:  2018-12-21       Impact factor: 4.036

10.  Integrin αvβ6-TGFβ-SOX4 Pathway Drives Immune Evasion in Triple-Negative Breast Cancer.

Authors:  Archis Bagati; Sushil Kumar; Peng Jiang; Jason Pyrdol; Angela E Zou; Anze Godicelj; Nathan D Mathewson; Adam N R Cartwright; Paloma Cejas; Myles Brown; Anita Giobbie-Hurder; Deborah Dillon; Judith Agudo; Elizabeth A Mittendorf; X Shirley Liu; Kai W Wucherpfennig
Journal:  Cancer Cell       Date:  2020-12-31       Impact factor: 38.585

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.